657—20.24(155A) Annual reporting of interstate distribution of compounded preparations.
	20.24(1) No later than April 1, 2022, and annually thereafter, each licensed pharmacy located in Iowa that distributed compounded preparations for human use interstate in the previous calendar year shall report compounding data to the NABP information sharing network.
	20.24(2) Compounding data may include, but not be limited to:
	a. 	Whether the pharmacy engaged in the following activities during the identified calendar year:
	(1)	Sterile human drug compounding;
	(2)	Nonsterile human drug compounding;
	(3)	Patient-specific compounding; and
	(4)	Non-patient-specific compounding.
	b. 	The number of prescription orders for compounded human drugs sent out from the pharmacy.
	c. 	The number of prescription orders for compounded human drugs dispensed at the pharmacy.
	d. 	The total number of prescription orders for compounded human drugs distributed interstate.
	e. 	The number of prescription orders for sterile compounded human drugs distributed interstate.
	f. 	The names of states into which the pharmacy distributed compounded human drugs during the identified calendar year.
	g. 	Whether compounded human drugs are distributed without patient-specific prescriptions.
[ARC 6076C, IAB 12/15/21, effective 1/19/22]